Patients with Headache. Other headache syndromes
Conditions
Interventions
Intervention 1: Intervention group: 50 patients who were treated with intranasal ketamine at a dose of 0.7 mg/kg (the maximum dose was considered 40 mg) in the form of three puffs inside each nostril
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Trauma patients with trauma pain with a pain score greater than 4 Age over 14 years Age less than 65 years
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time to start responding to treatment. Timepoint: Measurement of pain score at the beginning of the study (before the intervention) and 5, 10, 15, 30 and 60 minutes after the start of treatment. Method of measurement: Visual Analog Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Creating analgesia which patient's intensity pain goes below than 5. Timepoint: Measurement of pain score at the beginning of the study (before the intervention) and 5, 10, 15, 30 and 60 minutes after the start of treatment. Method of measurement: Visual analog scale (VAS).;The rate of complications in both groups. Timepoint: At the end of the study. Method of measurement: Calculate the number. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Soheila Azimi
Yazd University of Medical Sciences
Outcome results
None listed